Control of HIV Entry and Transcription, as a Possible Mechanism of the Antiviral Effects of T Lymphocytes in HIV Infection

  • J.-L. Virelizier
  • A. Amara
  • E. Oberlin
  • D. Rousset
  • M. Rodriguez
  • M. Kroll
Part of the NATO ASI Series book series (NSSA, volume 293)


For decades it has generally been assumed that T cell-mediated antiviral immunity acts through lysis of infected cells by specific T lymphocytes recognizing viral epitopes in the context of major histocompatibility antigens class I. Indeed, MHC class I restricted-, CD8 T cells are found in infected animals and do lyse infected cells in vitro in a highly specific manner. The MHC-dependence of this phenomenon was a remarkable discovery by Rolf Zinkernagel and Peter Dogherty (Nature, 1974), who were awarded a Nobel prize in 1996 precisely for this important finding. The “CTL assay” remains the best tool of research to asses the fine specificity and MHC restriction of antiviral CD8 T lymphocytes. The in vivo relevance of the CTL assay as a host defence mechanism, however, is not yet fully ascertained in most cases of viral infection or immunization.


Human Immunodeficiency Virus Type IKBa Expression ofThe National Academy ofSciences Cytolytic Mechanism Phorbol Ester Stimulation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aillet, F, Gougerot-Pocidalo, M.A., Virelizier, J.L. and Israel, N., 1994, AIDS Res.Hum.Retrovirus. 10: 405.CrossRefGoogle Scholar
  2. Alcami, J., Lain de Lera, T., Folgueira, L., Pedraza, M.A., Jacqué, J.M., Bachelerie, F., Noriega, A.R., Hay, R.T., Harrich, D., Gaynor, R.B., Virelizier, J-.L. and Arenzana-Seisdedos, F., 1995, Absolute dependence on κB responsive element for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes, EMBO J. 14: 1552.PubMedGoogle Scholar
  3. Arenzana-Seisdedos, F., Thompson, J., Rodriguez, M.S., Bachelerie, F., Thomas, D. and Hay, R.T., 1995, Inducible nuclear expression of newly synthesized IkB-alpha negatively regulates DNA-binding and transcriptional activities of NF-kB, Molecular And Cellular Biology. 15: 2689.Google Scholar
  4. Bachelerie, F., Alcami, J., Arenzana-Seisdedos, F. and Virelizier, J. L., 1991, HIV enhancer activity perpetuated by NF-kB induction on infection of monocytes, Nature. 350: 709.PubMedCrossRefGoogle Scholar
  5. Baeuerle, P. A., and Henkel, T., 1994, Function and activation of NF-kB in the immune system, Annual Review of Immunology. 12: 141.PubMedCrossRefGoogle Scholar
  6. Baltimore, D., and Beg, A. A., 1995, DNA-binding proteins-a butterfly flutters by, Nature, 373: 287.PubMedCrossRefGoogle Scholar
  7. Cocchi, F., Devico, A. L., Garzinodemo, A., Arya, S. K., Gallo, R. C. and Lusso, P., 1995, Identification of rantes, mip-1-alpha, and mip-1-beta as the major hiv-suppressive factors produced by CD8(+) T cells, Science., 270: 1811.PubMedCrossRefGoogle Scholar
  8. Cullen, B. R., and Garrett, E. D., 1992, A comparison of regulatory features in primate lentiviruses, Aids Research And Human Retroviruses, 8: 387.PubMedCrossRefGoogle Scholar
  9. Dragic, T, Litwin, V., Allaway, G.P., Martin, S.R., Huang, Y, Nagashima, K.A., Cayanan, C., Maddon, P.J., Koup, R.A., Moore, J.P., and Paxton, W. A., 1996, HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5, Nature. 381: 667.PubMedCrossRefGoogle Scholar
  10. D’Souza, M.P. and Harden, V. A., 1996, Chemokines and HIV second receptors.Confluence of two fields generates optimism in AIDS research, Science. 12: 1293.Google Scholar
  11. Fauci, A. S., Schnittman, S. M., Poli, G., Koenig, S. and Pantaleo, G., 1991, Immunopathogenic mechanisms in human-immunodeficiency-virus (HIV) infection, Annals Of Internal Medicine. 114: 678.PubMedCrossRefGoogle Scholar
  12. Feng, Y., Broder, C. C., Kennedy, P. E. and Berger, E. A., 1996, HIV-1 entry cofactor-functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor, Science. 272: 872.PubMedCrossRefGoogle Scholar
  13. Gaynor, R., 1992, Cellular transcription factors involved in the regulation of HIV-1 gene expression, AIDS. 6: 347.PubMedCrossRefGoogle Scholar
  14. Ghosh, G., van Duyne, G., Ghosh, S. and Sigler, P. B., 1995, Structure of NF-kappa B p50 homodimer bound to a kappa B site, Nature, 373: 303.PubMedCrossRefGoogle Scholar
  15. Greene, W. C., 1991, NF-kB and the activation of HIV-1 gene-expression, Journal of Acquired Immune Deficiency Syndromes. 4: 312.Google Scholar
  16. Guidotti, L. G., Ando, K, Hobbs, M. V, Ishikawa, T, Runkel, L., Schreiber, R. B., and Chisari, F., 1994, Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice, Proc.Natl.Acad.Sci.USA. 91: 3764.PubMedCrossRefGoogle Scholar
  17. Hay, R. T., Wakasugi, N., Virelizier, J. L. and Matthews, J., 1993, Regulation of the DNA-binding activity of the transcription factor NF-kB, Journal of Cellular Biochemistry. 10: 144.Google Scholar
  18. Hazan, U., Thomas, D., Alcami, J., Bachelerie, F., Israel, N., Yssel, H., Virelizier, J. L. and Arenzana-Seisdedos, F., 1990, Stimulation of a human T-cell clone with anti-CD3 or tumor necrosis factor induces NF-kB translocation but not human immunodeficiency virus 1 enhancer-dependent transcription, Proceedings of The National Academy of Sciences USA. 87: 7861.CrossRefGoogle Scholar
  19. Ho, D. D., Neuman, A.U., Perelson, A.S., Chen, W., Leonard, J. M. and Markowitz, M., 1995, Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection, Nature. 373: 123.PubMedCrossRefGoogle Scholar
  20. Israel, A., 1995, The rel/NF-kB and I-kB proteins-recent data on structure, function and regulation, MS-Medecine Sciences, 11: 1017.Google Scholar
  21. Keet, I. P., Krol, A., Roos, M.T., de Wolf, F., Miedema, F. and Coutinho, R. A., 1994, Predictors of disease progression in HIV-infected homosexual men with CD4+ cells 200.10.6 but free of AIDS-defining clinical disease, AIDS. 11: 1577.CrossRefGoogle Scholar
  22. Klenerman, P, Phillips, R. and McMichael, A., 1996, Cytotoxic T cell antagonism in HIV, Semin. Virol., 7: 31.CrossRefGoogle Scholar
  23. Jacque, J. M., Fernandez, B., Arenzana-Seisdedos, F., Thomas, D., Baleux, F., Virelizier, J. L. and Bachelerie, F., 1996, Permanent occupancy of the human immunodeficiency virus type 1 enhancer by NF-kappa B is needed for persistent viral replication in monocytes, Journal of Virology. 70: 2930.PubMedGoogle Scholar
  24. Malim, M. H. and Cullen, B. R., 1993, Rev and the fate of pre-mRNA in the nucleus: implications for the regulation of RNA processing in eukaryotes, Molecular & Cellular Biology. 13: 6180.Google Scholar
  25. Matthews, J. R., Wakasugi, N., Virelizier, J. L., Yodoi, J. and Hay, R. T., 1992, Thioredoxin regulates the DNA-binding activity of NF-kB by reduction of a disulfide bond involving cysteine 62, Nucleic Acids Research. 20: 3821.PubMedCrossRefGoogle Scholar
  26. Nabel, G., and Baltimore, D., 1987, An inducible transcription factor activates expression of human immunodeficiency virus in T cells, Nature. 326: 711.PubMedCrossRefGoogle Scholar
  27. Nabel, G. J., and Verma, I. M., 1993, Proposed NF-kB/I-kB family nomenclature, Genes & Development, 7: 2063.CrossRefGoogle Scholar
  28. Oberlin, E., Amara, A., Bachelerie, F., Bessia, C., Virelizier, J. L., Arenzana-Seisdedos, F., Schwartz, O., Heard, J. M., Clark-Lewis, I., Legier, D. F., Loetscher, M., Baggiolini, M. and Moser, B., 1996, The CXC chemokine SDF-1 is the ligand for Lestr/Fusin and prevents infection By T-cell-line-adapted HIV-1, Nature, 382: 833.PubMedCrossRefGoogle Scholar
  29. Paliard, X, Lee, A.Y., and Walker, C. M., 1996, RANTES, MIP-1 a and MIP-1β are not involved in the inhibition of HIV-1sf33 replication mediated by CD8+ T cell clones, AIDS. 10: 1317.PubMedCrossRefGoogle Scholar
  30. Poli, G., Kinter, A. L., Vicenzi, E. and Fauci, A. S., 1994, Cytokine regulation of acute and chronic HIV-infection in vitro from cell-lines to primary mononuclear-cells, Research In Immunology. 145: 578.PubMedCrossRefGoogle Scholar
  31. Pomerantz, R. J., Seshamma, T. and Trono, D., 1992, Efficient replication of human-immunodeficiency-virus type-1 requires a threshold level of rev-potential implications for latency, Journal Of Virology. 66: 1809.PubMedGoogle Scholar
  32. Rattner, A., Korner, M., Walker, M. D. and Citri, Y., 1993, NF-kB activates the HIV promoter in neurons, EMBO J., 12: 4261.PubMedGoogle Scholar
  33. Samson, M., Libert, F., Doranz, B.J., Rucker, J., Liesnard, C., Farber, C. M., Saragosti, S., Lapoumeroulie, C., Cognaux, J., Forceille, C., Muyldermans, G., Verhofstede, C., Burtonboy, G., Georges, M., Imai, T., Rana, S., Yi, Y. J., Smyth, R. J., Coliman, R. G., Doms, R. W., Vassart, G. and Parmentier, M., 1996, Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene, Nature. 382: 722.PubMedCrossRefGoogle Scholar
  34. Ten, R. M, Paya, C. V., Israel, N., Lebail, O., Mattei, M. G., Virelizier, J. L., Kourilsky, P. and Israel, A., 1992, The characterization of the promoter of the gene encoding the p50 subunit of NF-kB indicates that it participates in its own regulation, EMBO J. 11: 195.PubMedGoogle Scholar
  35. Verdin, E., Paras, P. and Van Lint, C., 1993, Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation, EMBO J., 12: 3249.PubMedGoogle Scholar
  36. Virelizier, J. L., 1990, Cellular activation and human-immunodeficiency-virus infection, Current Opinion In Immunology. 2: 409.CrossRefGoogle Scholar
  37. Zack, J. A., Arrigo, S. J., Weitsman, S. R., Go, A. S., Haislip, A. and Chen, I. S. Y., 1990, HIV-1 entry into quiescent primary lymphocytes-molecular analysis reveals a labile, latent viral structure, Cell. 61: 213.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • J.-L. Virelizier
    • 1
  • A. Amara
    • 1
  • E. Oberlin
    • 1
  • D. Rousset
    • 1
  • M. Rodriguez
    • 1
  • M. Kroll
    • 1
  1. 1.Unité d’Immunologie ViraleInstitut PasteurParisFrance

Personalised recommendations